{
    "clinical_study": {
        "@rank": "115881", 
        "arm_group": {
            "arm_group_label": "Single Arm Oral and IV Betrixaban", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a open label, single center, single oral dose, study of PRT054021, in healthy\n      subjects."
        }, 
        "brief_title": "A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers", 
        "completion_date": {
            "#text": "October 2007", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Subjects", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy adult men ages of 19 and 65 years old, inclusive\n\n          -  BMI of 18-35 kg/m2\n\n        Exclusion Criteria:\n\n          -  Clinically significant comorbid disease\n\n          -  History of substance abuse"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765868", 
            "org_study_id": "07-012"
        }, 
        "intervention": {
            "arm_group_label": "Single Arm Oral and IV Betrixaban", 
            "description": "Single Oral dose 80 mg betrixaban and Single IV (15 ml) carbon 14 80 micrograms Betrixaban administered over 15 minutes, 2 hours after the oral dose", 
            "intervention_name": "Betrixaban", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Betrixaban", 
            "Healthy", 
            "Bioavailability"
        ], 
        "lastchanged_date": "January 8, 2013", 
        "number_of_arms": "1", 
        "official_title": "A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2007", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Percent of orally absorbed dose", 
            "safety_issue": "No", 
            "time_frame": "over 72 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765868"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Portola Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Portola Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2007", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}